Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

× No keyword cloud information.

223 in total

1. Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.

Authors: H M Lloyd; J D Meares; J Jacobi
Journal: Nature Date: 1975-06-05 Impact factor: 49.962

2. Thyrotropin (TSH) release during altered adrenergic alpha and beta receptor influence.

Authors: U B Lauridsen; J Faber; T Friis; C Kirkegaard; J Nerup
Journal: Horm Metab Res Date: 1976-09 Impact factor: 2.936

3. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.

Authors: S S Yen; T M Siler; G W DeVane
Journal: N Engl J Med Date: 1974-04-25 Impact factor: 91.245

4. Growth hormone regulation by melatonin and serotonin.

Authors: G A Smythe; L Lazarus
Journal: Nature Date: 1973-07-27 Impact factor: 49.962

5. Suppression of prolactin release by a purified porcine PIF preparation and catecholamines infused into a rat hypophysial portal vessel.

Authors: J Takahara; A Arimura; A V Schally
Journal: Endocrinology Date: 1974-08 Impact factor: 4.736

6. Stimulation of human-growth-hormone secretion by L-dopa.

Authors: A E Boyd; H E Lebovitz; J B Pfeiffer
Journal: N Engl J Med Date: 1970-12-24 Impact factor: 91.245

7. Rapid induction of prolactin secretion by 3-iodo-L-tyrosine.

Authors: G A Smythe; J F Brandstater; L Lazarus
Journal: Neuroendocrinology Date: 1974 Impact factor: 4.914

8. Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa.

Authors: K Maeda; Y Kato; K Chihara; S Ogo; Y Iwasaki
Journal: J Clin Endocrinol Metab Date: 1975-08 Impact factor: 5.958

9. Evidence for dopaminergic control of thyrotrophin secretion in the rat.

Authors: T Ranta; P Männistö; J Tuomisto
Journal: J Endocrinol Date: 1977-03 Impact factor: 4.286

10. Effect of somatostatin on abnormal growth hormone and prolactin secretion in patients with the carcinoid syndrome.

Authors: A Gomez-Pan; M F Scanlon; M O Thorner; L H Rees; A V Schally; R Hall; G M Besser
Journal: Clin Endocrinol (Oxf) Date: 1979-06 Impact factor: 3.478

9 in total

1. Does metergoline selectively attenuate 5-HT mediated prolactin release?

Authors: P M Ellis; S E Gartside; C J Ware; G M Campling; P J Cowen
Journal: Psychopharmacology (Berl) Date: 1991 Impact factor: 4.530

Review 2. Regulation of thyroid-stimulating hormone (TSH) secretion in the fetus and neonate.

Authors: E Roti
Journal: J Endocrinol Invest Date: 1988-02 Impact factor: 4.256

3. Thyroid function tests in chronic liver disease: evidence for multiple abnormalities despite clinical euthyroidism.

Authors: M Borzio; R Caldara; F Borzio; V Piepoli; P Rampini; C Ferrari
Journal: Gut Date: 1983-07 Impact factor: 23.059

4. Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomas.

Authors: F Iannotta; P Fachinetti; A Fachinetti; G Pinotti; L Usellini
Journal: J Endocrinol Invest Date: 1983-10 Impact factor: 4.256

5. Inhibition by phospholipid liposomes of the prolactin and cortisol response to insulin hypoglycemia in man.

Authors: F Cavagnini; C Maraschini; A Dubini; G Ramella; L Danesi; R Fossati
Journal: Psychopharmacology (Berl) Date: 1984 Impact factor: 4.530

6. Estrogenic treatment does not modify the TSH and PRL responses to domperidone and TRH in patients with tumoral hyperprolactinemia.

Authors: E Ghigo; G Pogliano; C Campagnoli; A Bertagna; F Camanni; F Massara
Journal: J Endocrinol Invest Date: 1984-10 Impact factor: 4.256

Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.